BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37269557)

  • 1. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
    Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay.
    Galati L; Combes JD; Le Calvez-Kelm F; McKay-Chopin S; Forey N; Ratel M; McKay J; Waterboer T; Schroeder L; Clifford G; Tommasino M; Gheit T
    Microbiol Spectr; 2022 Apr; 10(2):e0148021. PubMed ID: 35225653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
    Naegele S; Ruiz-Torres DA; Zhao Y; Goss D; Faden DL
    J Mol Diagn; 2024 Mar; 26(3):179-190. PubMed ID: 38103593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.
    Damerla RR; Lee NY; You D; Soni R; Shah R; Reyngold M; Katabi N; Wu V; McBride SM; Tsai CJ; Riaz N; Powell SN; Babady NE; Viale A; Higginson DS
    JCO Precis Oncol; 2019; 3():. PubMed ID: 31485558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
    Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
    Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Mattox AK; D'Souza G; Khan Z; Allen H; Henson S; Seiwert TY; Koch W; Pardoll DM; Fakhry C
    Oral Oncol; 2022 May; 128():105805. PubMed ID: 35334415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma.
    Haring CT; Bhambhani C; Brummel C; Jewell B; Bellile E; Heft Neal ME; Sandford E; Spengler RM; Bhangale A; Spector ME; McHugh J; Prince ME; Mierzwa M; Worden FP; Tewari M; Swiecicki PL; Brenner JC
    Oncotarget; 2021 Jun; 12(13):1214-1229. PubMed ID: 34194620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
    Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
    Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor human papillomavirus DNA before diagnosis of HPV-positive head and neck cancer.
    Rettig EM; Faden DL; Sandhu S; Wong K; Faquin WC; Warinner C; Stephens P; Kumar S; Kuperwasser C; Richmon JD; Uppaluri R; Varvares M; Sethi R; Hanna GJ; Sroussi H
    Int J Cancer; 2022 Oct; 151(7):1081-1085. PubMed ID: 35262203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsies with Circulating Plasma HPV-DNA Measurements-A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer.
    Jakobsen KK; Bendtsen SK; Pallisgaard N; Friborg J; Lelkaitis G; Grønhøj C; von Buchwald C
    Clin Cancer Res; 2023 Oct; 29(19):3914-3923. PubMed ID: 37477909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis.
    Shenker RF; Razavian NB; D'Agostino RB; Mowery YM; Brizel DM; Hughes RT
    Oral Oncol; 2024 Jan; 148():106644. PubMed ID: 38006690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
    Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer.
    Xu Q; Dong H; Wang Z; Zhang P; Albers AE; Kaufmann AM; Zheng ZM; Qian X
    J Med Virol; 2023 May; 95(5):e28761. PubMed ID: 37212316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.